FERNANDEZ FERNANDO L 4
4 · BioCardia, Inc. · Filed Feb 10, 2020
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
FERNANDEZ FERNANDO L
Director
Transactions
- Exercise/Conversion
Common Stock
2020-01-13+567→ 6,315 total - Exercise/Conversion
Restricted Stock Units
2020-01-13−567→ 0 total→ Common Stock (567 underlying)
Footnotes (4)
- [F1]Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.
- [F2]The converted RSU corresponds to a 1:1 common stock issuance.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F4]On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which the final 567 RSUs remaining under the grant vested on January 13, 2020. The common stock into which such vested RSUs converted on January 13, 2020 is reported on Table I of this Form 4.